NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
NMD Pharma has raised $81.4M in total funding. The most recent round was Series B. The last funding was announced in November 2023.
NMD Pharma's investors include Jeito Capital, Novo Holdings, Inkef, Roche Venture Fund, CAPNOVA.
NMD Pharma is headquartered in Risskov, Denmark.
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
NMD Pharma is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NMD Pharma — Funding & Investors." VCBacked, November 15, 2023, https://www.vcbacked.co/company/nmd-pharma. Accessed October 29, 2026.
VCBacked. (2023). NMD Pharma — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/nmd-pharma
{{cite web |title=NMD Pharma — Funding & Investors |url=https://www.vcbacked.co/company/nmd-pharma |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated